Core Insights - Tianyu Biological (603717) reported sales of 45,900 pigs in October 2025, generating revenue of 55.0346 million yuan, with month-on-month changes of 60.17% and 68.01% respectively, and year-on-year changes of 71.81% and -10.51% [1] - From January to October 2025, the company sold a total of 321,900 pigs, representing a year-on-year increase of 25.05%, while total revenue reached 450.1972 million yuan, reflecting a year-on-year decline of 5.35% [1] - As of the end of October 2025, the company's pig inventory stood at 171,200 heads, showing a year-on-year increase of 1.27% but a month-on-month decrease of 4.79% [1]

证券代码：603717 证券简称：天域生物 公告编号：2025-103 天域生物科技股份有限公司 关于公司 2025 年度对外担保预计的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | | 被担保人名称 | 宜昌天域农牧有限公司（以下简称 "宜昌天域"） | | | --- | --- | --- | --- | | | | 宜都天乾农牧有限公司（以下简称 | | | | | "宜都天乾"） | | | | 本次担保金额 | 600.00 万元 | | | 担保对象 | 实际为其提供的担保余额 | 3,541.60 | 万元（宜昌天域） | | | | 1,021.49 | 万元（宜都天乾） | | | 是否在前期预计额度内 | 是 □否 | □不适用：_________ | | | 本次担保是否有反担保 | □是 否 | □不适用：_________ | 担保对象及基本情况 累计担保情况 | 对外担保逾期的累计金额（万元） | / | | --- | --- | | 截至本公告日上市公司及其控 ...

证券代码：603717 证券简称：天域生物 公告编号：2025-104 注：因四舍五入，以上数据可能存在尾差。 天域生物科技股份有限公司 2025 年 10 月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"）现将 2025 年 10 月养殖业 务主要经营数据公告如下： 一、2025 年 10 月养殖行业主要经营数据 2025 年 10 月，公司销售生猪 4.59 万头，销售收入 5,503.46 万元，环比变动 分别为 60.17%、68.01%，同比变动分别为 71.81%、-10.51%。 2025 年 1-10 月，公司累计销售生猪 32.19 万头，同比上升 25.05%；累计销 售收入 45,019.72 万元，同比下降 5.35%。 2025 年 10 月末，公司生猪存栏 17.12 万头，同比上升 1.27%，环比下降 4.79%。 二、特别提示 1 月份 销售数量（万头） 销售收入（万元） 期末库存量 当月 累计 当月 累计 （万头） 202 ...

Core Insights - Tianyu Biological (603717.SH) reported sales of 45,900 pigs in October 2025, with sales revenue of 55.03 million yuan, reflecting a month-on-month increase of 60.17% in volume and 68.01% in revenue, while year-on-year changes showed an increase of 71.81% in volume but a decrease of 10.51% in revenue [1][1][1] Sales Performance - For the period from January to October 2025, the company sold a total of 321,900 pigs, representing a year-on-year increase of 25.05% [1] - Cumulative sales revenue for the same period reached 450.20 million yuan, which is a year-on-year decrease of 5.35% [1] Inventory Status - As of the end of October 2025, the company's pig inventory stood at 171,200 heads, showing a year-on-year increase of 1.27% but a month-on-month decrease of 4.79% [1][1]

Core Insights - Tianyu Biological (603717.SH) reported a significant increase in pig sales and revenue for October 2025, with sales of 45,900 pigs and revenue of 55.03 million yuan, reflecting a month-on-month increase of 60.17% and 68.01% respectively, while year-on-year sales revenue decreased by 10.51% [1] Sales Performance - In the first ten months of 2025, the company sold a total of 321,900 pigs, representing a year-on-year increase of 25.05% [1] - Cumulative sales revenue for the same period reached 450 million yuan, showing a year-on-year decline of 5.35% [1] Inventory Status - As of the end of October 2025, the company's pig inventory stood at 171,200 heads, which is a year-on-year increase of 1.27% but a month-on-month decrease of 4.79% [1]

Core Insights - The aquaculture sector experienced a slight increase of 0.31% on November 7, with Tianyu Biological leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Aquaculture Sector Performance - Tianyu Biological (603717) closed at 9.46, up 3.05% with a trading volume of 169,600 shares and a turnover of 160 million yuan [1] - Other notable performers included: - Luoniushan (000735) at 8.12, up 2.40% with a volume of 1,088,900 shares [1] - Zhengbang Technology (002157) at 66.7, up 1.36% with a volume of 1,212,200 shares [1] - Muyuans (002714) at 49.71, up 0.93% with a volume of 285,500 shares [1] Capital Flow Analysis - The aquaculture sector saw a net inflow of 223 million yuan from institutional investors, while retail investors experienced a net outflow of 11.04 million yuan [2] - Key stocks with significant capital flow included: - Muyuan (002714) with a net inflow of 214 million yuan from institutional investors [3] - Jingji Zhino (000048) with a net inflow of 50.59 million yuan from institutional investors [3] - Zhengbang Technology (002157) with a net inflow of 24.48 million yuan from institutional investors [3]

Core Viewpoint - Tianyu Biological (formerly Tianyu Ecology) is currently facing a decline in stock price, with a closing price of 9.18 yuan and a drop of 2.75%, indicating a state of stock price break [1] Group 1: Company Background - Tianyu Biological was previously known as Tianyu Ecology, with a name change effective from August 21, 2024 [1] - The company was listed on the Shanghai Stock Exchange on March 27, 2017, with an initial issuance of 43.1779 million shares at a price of 14.63 yuan per share [1] - The total funds raised during the initial public offering amounted to 631.6927 million yuan, with a net amount of 570.1861 million yuan after expenses [1] Group 2: Financial Activities - In 2018, Tianyu Ecology announced a profit distribution plan, distributing a cash dividend of 0.20 yuan per share and a capital increase of 0.40 shares per share, resulting in a total share capital increase to 241,796,240 shares [2] - A special report on the use of previously raised funds indicated that the company issued 48.35 million shares at a price of 8.32 yuan per share, raising a total of 402.272 million yuan, with a net amount of 393.8655 million yuan after deducting issuance costs [3] - The total amount raised from the above fundraising activities is approximately 1.034 billion yuan [4] Group 3: Recent Developments - A revised proposal for a new issuance of A-shares aims to raise no more than 46.5235 million yuan, with the net proceeds intended for working capital and debt repayment [4] - The issuance will involve a related party transaction, with the shares being subscribed by an enterprise controlled by the company's actual controller, Luo Weiguo [4]

Group 1 - The core viewpoint of the news is that Tianyu Biological has shown a positive stock performance with a year-to-date increase of 16.77% and a recent rise of 2.06% in intraday trading [1] - As of November 5, the stock price is reported at 9.40 CNY per share, with a total market capitalization of 2.727 billion CNY [1] - The company has experienced significant trading activity, with net inflows of main funds amounting to 2.1875 million CNY and notable buying and selling volumes [1] Group 2 - Tianyu Biological, established on June 21, 2000, and listed on March 27, 2017, operates in the landscaping and environmental remediation sectors [2] - The company reported a revenue of 536 million CNY for the first nine months of 2025, reflecting a year-on-year decrease of 14.23%, and a net profit of -1.6109 million CNY, down 125.22% year-on-year [2] - The company is categorized under the agricultural and livestock industry, specifically in pig farming, and is involved in various concept sectors including ecological landscaping and PPP [2] Group 3 - Since its A-share listing, Tianyu Biological has distributed a total of 34.5423 million CNY in dividends, with no dividends paid in the last three years [3]

Core Insights - Tianyu Biological (603717) reported a closing price of 9.16 yuan as of October 31, 2025, reflecting a 1.55% increase from the previous week [1] - The company experienced a significant decline in revenue and net profit for the first three quarters of 2025, with a revenue of 536 million yuan, down 14.23% year-on-year [2] - The actual controller of the company changed to Luo Weiguo after the termination of the concerted action relationship with Shi Dongwei [3] Shareholder Changes - As of September 30, 2025, the number of shareholders increased to 21,700, a rise of 7.49% compared to June 30, 2025 [4] - The average number of shares held per shareholder decreased from 14,400 to 13,400 shares, with an average holding value of 118,400 yuan [1] Performance Disclosure - For the first three quarters of 2025, the company reported a net profit attributable to shareholders of -1.61 million yuan, a year-on-year decline of 152.22% [2] - The third quarter alone saw a revenue of 123 million yuan, down 38.69% year-on-year, with a net profit of -12.43 million yuan, a staggering decline of 7912.82% [2] - The company's debt ratio stood at 76.41%, with a gross profit margin of 13.16% [2] Company Announcements - The company plans to issue up to 71.03 million shares to Shanghai Daoyun Asset Management Co., Ltd., controlled by the new actual controller, to raise no more than 465 million yuan for working capital and debt repayment [3] - The board approved the continuation of commodity futures hedging activities, with a maximum margin of 50 million yuan and a contract value of up to 255 million yuan, valid from October 31, 2025, to October 30, 2026 [3]

Core Insights - The aquaculture sector experienced a 1.0% increase on October 31, with Tianyu Biological leading the gains [1] - The Shanghai Composite Index closed at 3954.79, down 0.81%, while the Shenzhen Component Index closed at 13378.21, down 1.14% [1] Aquaculture Sector Performance - Tianyu Biological (603717) closed at 9.16, up 4.93% with a trading volume of 254,000 shares and a transaction value of 234 million [1] - Huaying Agriculture (002321) closed at 2.90, up 4.69% with a trading volume of 654,900 shares and a transaction value of 188 million [1] - Other notable performers include *ST Tianshan (300313) up 3.34%, Luoniushan (000735) up 2.37%, and Xiaoming Co. (300967) up 1.65% [1] Capital Flow Analysis - The aquaculture sector saw a net inflow of 290 million from institutional investors, while retail investors experienced a net outflow of 190 million [2] - Major stocks like Muyuan Foods (002714) had a net inflow of 203 million, while Wens Foodstuffs (300498) had a net inflow of 61 million [3] - The overall trend indicates a shift in capital, with institutional investors showing confidence in the sector while retail investors are withdrawing [2][3]